International Journal Of Clinical Oncology

International Journal Of Clinical Oncology

国际临床肿瘤学杂志

  • 3区 中科院分区
  • Q3 JCR分区

期刊简介

《International Journal Of Clinical Oncology》是由Springer Singapore出版社于1996年创办的英文国际期刊(ISSN: 1341-9625,E-ISSN: 1437-7772),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 3区),本刊采用OA未开放获取模式(OA占比0.2869...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比75.71%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在247篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

International Journal Of Clinical Oncology审稿周期约为约2月。该刊近年未被列入国际预警名单,年发文量约247篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 247 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 172 / 333

48.5

学科:ONCOLOGY SCIE Q3 177 / 333

47

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 160 / 328

51.4

学科:ONCOLOGY SCIE Q3 188 / 328

42.84

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 193 / 322

40.2

学科:ONCOLOGY SCIE Q3 164 / 322

49.22

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.8 SJR:0.945 SNIP:1.151
学科类别 分区 排名 百分位
大类:Medicine 小类:Surgery Q1 80 / 597

86%

大类:Medicine 小类:Hematology Q2 43 / 151

71%

大类:Medicine 小类:Oncology Q2 165 / 428

61%

期刊发文

  • The global burden of alcohol-attributable cancers from 1990 to 2021: assessment and projection based on the global burden of disease study 202

    Author: Hu, Zhiqi; Gong, Zheng; Zhang, Ze; Wang, Yichen; Huang, Ying; Huang, Hongbo; Wei, Tingting; Li, Jiaying; Zhang, Aijie; Li, Yunhai; Li, Fan

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 31, Issue 4, pp. 598-610. DOI: 10.1007/s10147-025-02927-7

  • Prognostic value of creatinine-cystatin C ratio in individuals with cancer: a meta-analysi

    Author: Zhou, Wei; Wang, Xinyu; Wang, Tingting; Chen, Shujuan; Yang, Jinhong; Guo, Ying

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 31, Issue 4, pp. 587-597. DOI: 10.1007/s10147-025-02885-0

  • Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cance

    Author: Xu, Binwen; Wang, Hanxiao; Zhang, Chengcheng; Luo, Tao; Xiong, Jie; Ran, Xingqiang; Liu, Junhong; Shi, Guidong; Fu, Maoyong

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-026-03018-x

  • How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma

    Author: Li, Hongru; Zhang, Jiayue; Shen, Linxing; Luo, Pei

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-026-03014-1

  • The clinical application value of body composition in predicting the prognosis of rectal cance

    Author: Ouyang, Yongpeng; Li, Ding; Xia, Binsong; Xia, Kunjian

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-026-03015-0

  • A multinational pilot survey of clinical practice patterns in tumor-specific mesocolic excision and complete lymph node dissection for colorectal cance

    Author: Efetov, Sergey; Perez, Rodrigo; Hompes, Roel; Zubayraeva, Albina; Julia, Guilherme Pagin Sao; Campana, Juan Pablo; Campanati, Renato; Camargo, Michel Gardere; De Castro Cotti, Guilherme Cutait; Chanturia, Mamuka; Daneri, Maria Dolores; Dacanal, Francisco Marques; Garcia, Ana Maria; Ghezzi, Tiago Leal; Hanan, Bernardo; Kayaalp, Cuneyt; Khorobrykh, Tatiana; Liu, Zheng; Martinez, Carlos Augusto Real; Seva-Pereira, Gustavo; Rychkova, Arina; de Medeiros Silva, Andre Araujo; Yazyi, Federico

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-026-03016-z

  • Breast cancer burden among women of reproductive age in China, Japan, and South Korea, 1990-2021: a systematic analysis from the Global Burden of Disease Study 202

    Author: Rong, Zhiyuan

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-026-02989-1

  • Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinom

    Author: Kikuchi, Eiji; Van der Heijden, Michiel S.; Valderrama, Begona P.; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas

    Journal: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10147-025-02950-8